These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36591354)

  • 1. Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study.
    Corken A; Ware J; Dai J; Arthur JM; Smyth S; Davis CL; Liu J; Harville TO; Phadnis MA; Mehta JL; Rahmatallah Y; Jain N
    Kidney360; 2022 Dec; 3(12):2036-2047. PubMed ID: 36591354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease.
    Jain N; Corken A; Arthur JM; Ware J; Arulprakash N; Dai J; Phadnis MA; Davis O; Rahmatallah Y; Mehta JL; Hedayati SS; Smyth S
    Vascul Pharmacol; 2023 Feb; 148():107143. PubMed ID: 36682595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients.
    Spoto B; Leonardis D; Parlongo RM; Pizzini P; Pisano A; Cutrupi S; Testa A; Tripepi G; Zoccali C; Mallamaci F
    Nutr Metab Cardiovasc Dis; 2012 Nov; 22(11):981-8. PubMed ID: 21906921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.
    Gupta J; Mitra N; Kanetsky PA; Devaney J; Wing MR; Reilly M; Shah VO; Balakrishnan VS; Guzman NJ; Girndt M; Periera BG; Feldman HI; Kusek JW; Joffe MM; Raj DS;
    Clin J Am Soc Nephrol; 2012 Dec; 7(12):1938-46. PubMed ID: 23024164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet P2Y12 Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimental Human Model.
    Thomas MR; Outteridge SN; Ajjan RA; Phoenix F; Sangha GK; Faulkner RE; Ecob R; Judge HM; Khan H; West LE; Dockrell DH; Sabroe I; Storey RF
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2562-70. PubMed ID: 26515417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of fish oil supplementation on markers of inflammation in chronic kidney disease patients.
    Deike E; Bowden RG; Moreillon JJ; Griggs JO; Wilson RL; Cooke M; Shelmadine BD; Beaujean AA
    J Ren Nutr; 2012 Nov; 22(6):572-7. PubMed ID: 22285316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential membrane expression of Toll-like receptors and intracellular cytokine induction in peripheral blood monocytes of patients with chronic kidney disease and diabetic nephropathy.
    Zikou X; Tellis CC; Rousouli K; Dounousi E; Siamopoulos KC; Tselepis AD
    Nephron Clin Pract; 2014; 128(3-4):399-406. PubMed ID: 25592836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin and P2Y12 Inhibitors in platelet-mediated activation of neutrophils and monocytes.
    Schrottmaier WC; Kral JB; Badrnya S; Assinger A
    Thromb Haemost; 2015 Aug; 114(3):478-89. PubMed ID: 25904241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of clopidogrel intake in renal transplant patients: effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers.
    Graff J; Harder S; Wahl O; Scheuermann EH; Gossmann J
    Clin Pharmacol Ther; 2005 Nov; 78(5):468-76. PubMed ID: 16321613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.
    Fiotti N; Giansante C; Ponte E; Delbello C; Calabrese S; Zacchi T; Dobrina A; Guarnieri G
    Atherosclerosis; 1999 Jul; 145(1):51-60. PubMed ID: 10428295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Fibroblast Growth Factor 23 with Markers of Inflammation and Leukocyte Transmigration in Chronic Kidney Disease.
    Wallquist C; Mansouri L; Norrbäck M; Hylander B; Jacobson SH; Larsson TE; Lundahl J
    Nephron; 2018; 138(4):287-295. PubMed ID: 29301137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not all inflammatory markers are linked to kidney function: results from a population-based study.
    Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
    Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
    Baber U; Li SX; Pinnelas R; Pocock SJ; Krucoff MW; Ariti C; Gibson CM; Steg PG; Weisz G; Witzenbichler B; Henry TD; Kini AS; Stuckey T; Cohen DJ; Iakovou I; Dangas G; Aquino MB; Sartori S; Chieffo A; Moliterno DJ; Colombo A; Mehran R
    Circ Cardiovasc Interv; 2018 Mar; 11(3):e006144. PubMed ID: 29870385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of lipid-lowering treatment on platelet reactivity and platelet-leukocyte aggregation in diabetic patients without and with chronic kidney disease: a randomized trial.
    Almquist T; Jacobson SH; Lins PE; Farndale RW; Hjemdahl P
    Nephrol Dial Transplant; 2012 Sep; 27(9):3540-6. PubMed ID: 22700717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bi-directional effect of markers of inflammation and a decrease in glomerular filtration rate in chronic kidney disease.
    Murkamilov IT
    Klin Lab Diagn; 2022 Jan; 67(1):37-42. PubMed ID: 35077068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High levels of PF4, VEGF-A, and classical monocytes correlate with the platelets count and inflammation during active tuberculosis.
    Urbán-Solano A; Flores-Gonzalez J; Cruz-Lagunas A; Pérez-Rubio G; Buendia-Roldan I; Ramón-Luing LA; Chavez-Galan L
    Front Immunol; 2022; 13():1016472. PubMed ID: 36325331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease induces inflammation by increasing Toll-like receptor-4, cytokine and cathelicidin expression in neutrophils and monocytes.
    Grabulosa CC; Manfredi SR; Canziani ME; Quinto BMR; Barbosa RB; Rebello JF; Batista MC; Cendoroglo M; Dalboni MA
    Exp Cell Res; 2018 Apr; 365(2):157-162. PubMed ID: 29481790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome.
    Ilardi F; Gargiulo G; Paolillo R; Ferrone M; Cimino S; Giugliano G; Schiattarella GG; Verde N; Stabile E; Perrino C; Cirillo P; Coscioni E; Morisco C; Esposito G
    J Cardiovasc Med (Hagerstown); 2020 Sep; 21(9):660-666. PubMed ID: 32520854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating monocyte-platelet aggregates with different monocyte subsets and their association with disease severity in chronic kidney disease.
    Liang S; Wang YL; Ji Y; Na SP; Jia XB; Zhao SL; Lyu HY; Yuan XY; Bao YS
    Am J Med Sci; 2023 May; 365(5):443-449. PubMed ID: 36796723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.
    Lee BT; Ahmed FA; Hamm LL; Teran FJ; Chen CS; Liu Y; Shah K; Rifai N; Batuman V; Simon EE; He J; Chen J
    BMC Nephrol; 2015 May; 16():77. PubMed ID: 26025192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.